Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 17.61% is 46% below its 5-year average of 32.63%, near the low end of its 5-year range (11.68%–96.72%).
62.99% below its 12-month average of 47.59%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 16.58%.
GROSS MARGIN
17.61%
GROSS MARGIN AVG TTM
47.59%
GROSS MARGIN AVG 3Y
46.19%
GROSS MARGIN AVG 5Y
32.63%
GROSS MARGIN AVG 10Y
41.53%
GROSS MARGIN AVG 15Y
40.07%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-62.99%
CURRENT VS 3Y AVG
-61.87%
CURRENT VS 5Y AVG
-46.04%
CURRENT VS 10Y AVG
-57.59%
CURRENT VS 15Y AVG
-56.06%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.60%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
-62.21%
vs the sector median at left
Acadia Healthcare Company, Inc.
Market Cap
$2.69B
Gross Margin
17.61%
TTM Avg
47.59%
3Y Avg
46.19%
5Y Avg
32.63%
Market Cap
$2.69B
Gross Margin
31.95%
TTM Avg
33.09%
3Y Avg
31.97%
5Y Avg
31.83%
Market Cap
$2.64B
Gross Margin
56.20%
TTM Avg
28.10%
3Y Avg
28.10%
5Y Avg
28.10%
Market Cap
$2.64B
Gross Margin
84.05%
TTM Avg
-197.31%
3Y Avg
-176.53%
5Y Avg
-71811.06%
Market Cap
$2.51B
Gross Margin
-61.96%
TTM Avg
-19.42%
3Y Avg
-14.39%
5Y Avg
23.74%
Market Cap
$2.87B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$2.88B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acadia Healthcare Company, Inc. (ACHC) | $2.69B | 17.61% | 47.59% | 46.19% | 32.63% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 31.95% | 33.09% | 31.97% | 31.83% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | 56.20% | 28.10% | 28.10% | 28.10% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | 84.05% | -197.31% | -176.53% | -71811.06% |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 76.16% | 74.55% | 74.69% | 74.35% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -61.96% | -19.42% | -14.39% | 23.74% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 58.69% | 59.64% | 63.22% | 64.62% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 0.00% | 0.00% | 0.00% | 0.00% |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | 0.00% | 0.00% | 0.00% | 0.00% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 18.57% | 22.55% | 18.71% | 13.63% |
Gross Margin
17.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 16.58% |
| 2026-03-31 | 16.53% |
| 2025-12-31 | 11.68% |
| 2025-09-30 | 96.43% |
| 2025-06-30 | 96.72% |
| 2025-03-31 | 32.60% |
| 2024-12-31 | 96.31% |
| 2024-09-30 | 96.37% |
| 2024-06-30 | 23.96% |
| 2024-03-31 | 22.73% |
| 2023-12-31 | 22.97% |
| 2023-09-30 | 23.97% |
| 2023-06-30 | 43.56% |
| 2023-03-31 | 40.76% |
| 2022-12-31 | 42.01% |
| 2022-09-30 | 43.28% |
| 2022-06-30 | 44.08% |
| 2022-03-31 | 41.71% |
| 2021-12-31 | 42.02% |
| 2021-09-30 | 43.35% |
| 2021-06-30 | 42.99% |
| 2021-03-31 | 40.92% |
| 2020-12-31 | 40.17% |
| 2020-09-30 | 42.99% |
| 2020-06-30 | 39.71% |
| 2020-03-31 | 39.28% |
| 2019-12-31 | 41.02% |
| 2019-09-30 | 40.90% |
| 2019-06-30 | 41.58% |
| 2019-03-31 | 39.58% |
| 2018-12-31 | 40.35% |
| 2018-09-30 | 41.21% |
| 2018-06-30 | 41.64% |
| 2018-03-31 | 40.60% |
| 2017-12-31 | 42.03% |
| 2017-09-30 | 42.21% |
| 2017-06-30 | 42.42% |
| 2017-03-31 | 40.50% |
| 2016-12-31 | 41.20% |
| 2016-09-30 | 40.27% |
| 2016-06-30 | 41.91% |
| 2016-03-31 | 40.39% |
| 2015-12-31 | 41.78% |
| 2015-09-30 | 41.62% |
| 2015-06-30 | 41.84% |
| 2015-03-31 | 39.27% |
| 2014-12-31 | 38.82% |
| 2014-09-30 | 37.96% |
| 2014-06-30 | 37.76% |
| 2014-03-31 | 36.63% |
| 2013-12-31 | 37.57% |
| 2013-09-30 | 38.50% |
| 2013-06-30 | 37.81% |
| 2013-03-31 | 36.14% |
| 2012-12-31 | 37.51% |
| 2012-09-30 | 37.24% |
| 2012-06-30 | 95.15% |
| 2012-03-31 | 95.12% |
| 2011-12-31 | 34.28% |
| 2011-09-30 | 31.56% |
| 2011-06-30 | 1.95% |
| 2011-03-31 | 94.46% |
| 2010-12-31 | 23.48% |
| 2010-09-30 | 34.02% |
